Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Canopy Growth Strengthens Commitment to Cannabis-Based Medicines Through Completion of Canopy Health Innovations Acquisition
TORONTO and SMITHS FALLS, ON, Aug. 7, 2018 /PRNewswire/ – Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“Canopy Growth” or the “Company”) is pleased to announce that it has completed the previously announced acquisition of Canopy Health Innovations Inc. (“CHI”), including the subsidiary operations of Canopy Animal Health Inc. (“CAH”). The Company believes its strategy of integrating and aligning CHI’s clinical platform with the international work of Spectrum Cannabis, will accelerate its comprehensive research programs, build evidence around Canopy products and formulations and ultimately improve patient access to medical cannabis globally.
Canopy Growth continues to expand